Prosecution Insights
Last updated: October 26, 2026

Abigail Marie Bock, USPTO Patent Examiner

Listed by the USPTO as BOCK, ABIGAIL MARIE

Tech Center 3700 • Art Units: 3783 3791 3794

This examiner grants 91% of resolved cases

Analysis

BOCK, ABIGAIL MARIE is assigned to Technology Center 3700 and art unit 3783. The record contains 156 resolved cases and shows a 91.0% allowance rate. The median time to allowance is 1069 days. Interview lift is 7.3%, indicating a modest positive association between interviews and allowance outcomes.

The listed companies are Biosense Webster (Israel) Ltd., Olympus Corporation, and Abbott Laboratories. The listed firms are OLIFF PLC, Troutman Pepper Locke LLP, and ARENTFOX SCHIFF LLP. The high allowance rate supports favorable expectation setting, while the interview figure suggests that interviews may be useful as a supplemental rather than central prosecution tactic.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

91.0%
Allow Rate
+21.0% vs TC avg
197
Total Applications
+7.3%
Interview Lift
1069
Avg Prosecution Days
Based on 156 resolved cases, 2023–2026

Rejection Statute Breakdown

3.4%
§101 Eligibility
20.2%
§102 Novelty
55.9%
§103 Obviousness
14.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18750574 WEARABLE ELECTRONIC DEVICE COMPRISING BIOMETRIC SENSOR Final Rejection Samsung Electronics Co., Ltd.
18704602 BIOPOTENTIAL MEASUREMENT DEVICE, INFORMATION PROCESSING APPARATUS, AND BIOPOTENTIAL MEASUREMENT METHOD Final Rejection SONY GROUP CORPORATION
18761381 MEDICAL INTERVENTION ARRANGEMENT AND COMPUTER-IMPLEMENTED METHOD FOR DETERMINING POSITION INFORMATION OF A MEDICAL INSTRUMENT Non-Final OA Siemens Healthineers AG
18969596 APPARATUSES FOR CATHETER-BASED ELECTROPHYSIOLOGY Non-Final OA Biosense Webster (Israel) Ltd.
18824488 Biased Electrodes for Improved Tissue Contact and Current Delivery Non-Final OA Biosense Webster (Israel) Ltd.
18433795 APPARATUS AND METHOD FOR ABLATION WITH VARIABLE ELECTRODE SPACING AND FLUID MEDIUM Final Rejection Biosense Webster (Israel) Ltd.
18230934 PLANAR MULTI-ELECTRODE CATHETERS Non-Final OA Biosense Webster (Israel) Ltd.
18984155 ULTRASONIC TREATMENT INSTRUMENT Non-Final OA OLYMPUS MEDICAL SYSTEMS CORP.
18928294 TREATMENT DEVICE Non-Final OA OLYMPUS CORPORATION
18941620 ELECTROSURGICAL INSTRUMENT WITH COMMUNICATION INTERFACE AND ELECTROSURGICAL GENERATOR Non-Final OA OLYMPUS WINTER & IBE GMBH
18544653 MODULAR ELECTROSURGICAL GENERATOR SYSTEM Non-Final OA Olympus Winter & IBE GmbH
18541886 ELECTRO SURGICAL GENERATOR FOR FEEDING AND CONTROLLING ELECTRO SURGICAL INSTRUMENTS Final Rejection OLYMPUS WINTER & IBE GMBH
18540534 METHOD FOR OPERATING AN ELECTRO SURGICAL GENERATOR Final Rejection OLYMPUS WINTER & IBE GMBH

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Abigail Marie Bock's allowance rate?

91.0% of resolved applications examined by Abigail Marie Bock were allowed (156 resolved cases), compared with 67.3% across Art Unit 3783 over the last five years.

Does an interview help with examiner Abigail Marie Bock?

This examiner's interview lift is +7.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Abigail Marie Bock take to allow a patent?

Applications allowed by Abigail Marie Bock took 1,069 days on average from filing to allowance.

Which art unit does examiner Abigail Marie Bock work in?

Abigail Marie Bock examines applications in Art Unit 3783 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month